The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta-adrenoceptor agonists.
Jack
D
D
Glaxo Holdings Limited, Ware, Hertfordshire.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000420:Albuterol / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D002395:Catecholamines / Q000378:metabolism; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D011943:Receptors, Adrenergic, beta / Q000187:drug effects*; D000068299:Salmeterol Xinafoate
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D011943:Receptors, Adrenergic, beta; D000068299:Salmeterol Xinafoate; D000420:Albuterol; D004837:Epinephrine